12
13
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T27715 |
KBP-7018
KBP 7018 |
||
KBP-7018 is a potent, selective tyrosine kinase inhibitor with effects on three fibrotic kinases c-KIT, RET, and PDGFR (IC50 values are 10nM, 7.6 nM and 25nM respectively). | |||
T70382 |
KBP-7018 HCl
|
||
KBP-7018 Hydrochloride is a novel, tyrosine kinase-selective inhibitor with potent effects on three fibrotic kinases (c-KIT, PDGFR, and RET). | |||
T80731 |
Zifanocycline TFA
KBP-7072 TFA |
||
Zifanocycline TFA (KBP-7072) 是一种半合成的氨基糖苷类抗生素,具有口服活性并能抑制细菌核糖体功能。它对广泛的革兰氏阳性菌和阴性菌示出了体外抗菌活性,包括多种耐药病原体。Zifanocycline TFA 适用于急性细菌性皮肤及皮肤结构感染、社区获得性细菌性肺炎和复杂的腹腔感染的研究。 | |||
T70381 |
GSK2793660 free base
|
||
GSK-2793660 is a cathepsin C inhibitor that may be useful in the treatment of cystic fibrosis, noncystic fibrosis bronchiectasis, ANCA-associated vasculitis and bronchiectasis. | |||
T18610 |
PROTAC FKBP Degrader-3
|
Others; PROTACs | Others; PROTAC |
PROTAC FKBP Degrader-3 is a PROTAC that comprises a FKBP ligand binding group, a linker and an VHL binding group. PROTAC FKBP Degrader-3 is a potent FKBP degrader[1]. | |||
T11292 |
FKBP12 PROTAC dTAG-7
dTAG-7 |
Epigenetic Reader Domain; PROTACs | Chromatin/Epigenetic; PROTAC |
FKBP12 PROTAC dTAG-7 (dTAG-7) is a heterobifunctional compound that selectively degrades the BET bromodomain transcriptional co-activator BRD4 by connecting BET bromodomains to the E3 ubiquitin ligase CRBN. Additionally, it serves as a degrader of FKBP12F36V when FKBP12F36V is expressed in-frame with a targeted protein. | |||
T18597 |
dFKBP-1
|
Others; PROTACs | Others; PROTAC |
dFKBP-1 is a potent and PROTAC-based FKBP12 degrader. dFKBP-1 incorporates the ligand SLF of FKBP12, the Thalidomide based cereblon ligand and a linker[1]. | |||
T13694 |
FKBP12 PROTAC RC32
RC32 |
Others; PROTACs | Others; PROTAC |
FKBP12 PROTAC RC32 contains conjugation of Rapamycin and a ligand for an E3 ubiquitin ligase.FKBP12 PROTAC RC32 (RC32) is a potent FKBP12 degrader based on PROTAC technology. | |||
T79184 | FKBP51F67V-selective antagonist Ligand2 | FKBP | Apoptosis; Autophagy; Immunology/Inflammation |
FKBP51F67V-selective antagonist Ligand2(示例3-3)是针对杏仁核中由FKBP51 F67V过表达引起的焦虑表型的有效逆转剂。本物质特异性地结合到FKBP51 F67V,与野生型FKBP51及FKBP52无亲和力。 | |||
T71840 |
FKBP12-IN-Q2
|
||
FKBP12-IN-Q2 is an inhibitor of FKBP12. | |||
T11291 |
FKBP12 PROTAC dTAG-13
dTAG-13 |
Epigenetic Reader Domain; PROTACs | Chromatin/Epigenetic; PROTAC |
FKBP12 PROTAC dTAG-13 (dTAG-13) is a degrader of FKBP12F36V with expression of FKBP12F36V in-frame with a protein of interest. FKBP12 PROTAC dTAG-13 (dTAG-13) also is a selective degrader of BET bromodomain transcriptional co-activator BRD4 by bridging BET bromodomains to an E3 ubiquitin ligase CRBN. FKBP12 PROTAC dTAG-13 (dTAG-13) is a PROTAC-based heterobifunctional degrader. | |||
T74144 | Zifanocycline | ||
Zifanocycline (KBP-7072) 为半合成第三代氨甲基环素类抗生素,通过抑制细菌核糖体功能而发挥作用。它对革兰氏阳性菌和革兰氏阴性菌[包括多重耐药病原体]显示出广泛的体外抗菌活性。适用于口服和注射形式,Zifanocycline 主要用于研究治疗急性细菌性皮肤及其结构感染、社区获得性细菌性肺炎以及复杂腹腔感染。 |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPY-03993 |
KIAA1279 Protein, Human, Recombinant (His & GST)
KBP,KIAA1279,TTC2 |
Human | Baculovirus Insect Cells |
KIAA1279 Protein, Human, Recombinant (His & GST) is expressed in Baculovirus insect cells with His and GST tag. The predicted molecular weight is 99.6 kDa and the accession number is Q96EK5. | |||
TMPY-00589 |
KIAA1279 Protein, Human, Recombinant
TTC2,KIAA1279,KBP |
Human | Baculovirus Insect Cells |
KIAA1279 Protein, Human, Recombinant is expressed in Baculovirus insect cells. The predicted molecular weight is 72 kDa and the accession number is Q96EK5. | |||
TMPJ-01076 |
FKBP4 Protein, Human, Recombinant (His)
FKBP4,HSP-binding immunophilin,immunophilin FKB... |
Human | E. coli |
FKBP4 act as a regulator of microtubule dynamics by inhibiting MAPT/TAU ability to promote microtubule assembly. FKBP4 may play a role in the intracellular trafficking of heterooligomeric forms of steroid hormone receptors between cytoplasm and nuclear compartments, it also may have a protective role against oxidative stress in mitochondria. The isomerase activity controls neuronal growth cones via regulation of TRPC1 channel opening. | |||
TMPJ-01068 |
FKBP25/FKBP3 Protein, Human, Recombinant (His)
25 kDa FKBP,FKBP-3,Peptidyl-prolyl cis-tra... |
Human | E. coli |
FKBP25 contains 1 PPIase FKBP-type domain, belongs to the FKBP-type PPIase family. FK506- and rapamycin-binding proteins (FKBPs) constitute a family of receptors for the two immunosuppressants which inhibit T-cell proliferation by arresting two distinct cytoplasmic signal transmission pathways. FKBP3 is a cis-trans prolyl isomerase enzyme that binds the immunosuppressants FK506 and rapamycin, as well as histone deacetylases, the transcription factor YY1, casein kinase II, and nucleolin. It has a... | |||
TMPY-01662 |
FKBP12 Protein, Mouse, Recombinant (His)
FK506 binding protein 1A,Fkbp1,FKBP12,F |
Mouse | E. coli |
FKBP12 Protein, Mouse, Recombinant (His) is expressed in E. coli expression system with His tag. The predicted molecular weight is 12.7 kDa and the accession number is P26883. | |||
TMPY-00510 |
FKBP11 Protein, Human, Recombinant (mFc)
FKBP19,FK506 binding protein 11, 19 kDa |
Human | HEK293 Cells |
FKBP11 serve as biomarker and/or therapeutic target for Acute aortic dissection (AAD). FKBP11 during the development of HCC and FKBP11 has the potential to be an early marker for HCC. | |||
TMPY-00808 |
FKBP12 Protein, Human, Recombinant (His)
FKBP12,FKBP1,FKBP-1A,PKCI2,FK506 ... |
Human | E. coli |
FKBP12 Protein, Human, Recombinant (His) is expressed in E. coli expression system with His tag. The predicted molecular weight is 12.9 kDa and the accession number is P62942. | |||
TMPY-02259 |
FKBP25/FKBP3 Protein, Human, Recombinant (GST)
FKBP-25,PPIase,FKBP25,FK506 binding protei... |
Human | E. coli |
FKBP3 is a member of FK506-binding proteins (FKBPs). miR-145-5p overexpression suppressed cell proliferation of NSCLC cells which was abrogated by FKBP3 overexpression, that FKBP3/Sp1/HDAC2/p27 control cell proliferation during NSCLC development. | |||
TMPY-03385 |
FKBP14 Protein, Human, Recombinant (His)
IPBP12,EDSKMH,FK506 binding protein 14, 22 kDa,FKBP... |
Human | HEK293 Cells |
FKBP14 belongs to the FK506-binding protein family. It contains 2 EF-hand domains and one PPIase FKBP-type domain. FKBP14 can be detected in the lumen of the endoplasmic reticulum where it is thought to accelerate the folding of proteins during protein synthesis. Truncation of the amino-terminus of FKBP14 significantly decreases peptidyl prolyl cis-trans isomerase activity, therefore implicating that the PPIase FKBP-type domain must be located at the N-terminus. Defects in FKBP14 can cause Ehler... | |||
TMPY-03148 |
FKBP7 Protein, Human, Recombinant (His)
FK506 binding protein 7,FKBP23,PPIase |
Human | HEK293 Cells |
FKBP7 Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 23.8 kDa and the accession number is Q9Y680-2. | |||
TMPJ-00919 |
FKBP2 Protein, Human, Recombinant (His)
also named 13 kDa FK506-binding protein,FK506-binding protei... |
Human | HEK293 Cells |
Peptidyl-prolyl cis-trans isomerase FKBP2(FKBP2 for short), also named 13 kDa FK506-binding protein, FK506-binding protein 2, Immunophilin FKBP13, Rotamase, is a endoplasmic reticulum peripheral membrane protein. It contains 1 PPIase FKBP-type domain and belongs to the FKBP-type PPIase family, FKBP2 subfamily which takes part in immunoregulation and basic cellular processes involving protein folding and trafficking. FKBP2 is a cis-trans prolyl isomerase that binds the immunosuppressants FK506 an... | |||
TMPY-02962 |
FKBP7 Protein, Human, Recombinant (hFc)
FKBP23,PPIase,FK506 binding protein 7 |
Human | HEK293 Cells |
FKBP7 Protein, Human, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 49.4 kDa and the accession number is Q9Y680-2. | |||
TMPY-01555 |
PRAC Protein, Human, Recombinant (His & SUMO)
PRAC,C17orf92 |
Human | E. coli |
The PRAC gene is located on chromosome 17 at position 17q21, about 4 kbp downstream from the homeodomain Hoxb-13 gene. The pathogenesis of PCa may be due to the expression levels of PRAC protein, and this protein can serve as a potential biomarker for the management of PCa. |